Meng-Yu Wang Selected Research

parkin protein

11/2019

Post-translational modification of Parkin and its research progress in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meng-Yu Wang Research Topics

Disease

3	Neoplasms (Cancer) 02/2024 - 01/2017
2	Fatty Liver 10/2022 - 01/2022
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 01/2009
1	Adenocarcinoma 02/2024
1	Ulcerative Colitis 10/2022
1	Colitis 10/2022
1	Alcoholic Fatty Liver 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Obesity 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Mental Disorders (Mental Disorder) 10/2021
1	Ganglion Cysts (Ganglion) 01/2020
1	Insulin Resistance 12/2019
1	Parkinsonian Disorders (Parkinsonism) 11/2019
1	False Aneurysm (Pseudoaneurysm) 05/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Fibrosarcoma 01/2017
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2016
1	Stroke (Strokes) 10/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2011
1	Carcinoma (Carcinomatosis) 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

2	LTX-315IBA 01/2019 - 01/2017
2	Peptides (Polypeptides)IBA 01/2019 - 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 02/2024
1	Docetaxel (Taxotere)FDA Link 02/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024
1	Immune Checkpoint InhibitorsIBA 02/2024
1	Leucovorin (Folinic Acid)FDA Link 02/2024
1	sintilimabIBA 02/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	Dextran SulfateIBA 10/2022
1	NF-kappa B (NF-kB)IBA 10/2022
1	ChemokinesIBA 10/2022
1	LigandsIBA 10/2022
1	Drinking WaterIBA 10/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2022
1	16S Ribosomal RNAIBA 01/2022
1	AmmoniaIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 12/2019
1	parkin proteinIBA 11/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2019
1	AlarminsIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	SCR-4026IBA 10/2016
1	Oxygen (Dioxygen)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2016
1	N-Methylaspartate (NMDA)IBA 10/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 10/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	AndrogensIBA 01/2009
1	Conditioned Culture MediaIBA 01/2009

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 02/2024 - 01/2019
2	Immunotherapy 01/2019 - 01/2017
1	Neoadjuvant Therapy 02/2024
1	Acupuncture Points (Acupuncture Point) 10/2021
1	Moxibustion 10/2021
1	Stents 05/2019
1	Stem Cell Transplantation 01/2011